Texas Top Legal Officer Takes Legal Action Against Acetaminophen Makers Concerning Autism Spectrum Claims

Courtroom Action
The Texas Attorney General, a Trump ally who is running for US Senate, alleged the drug companies of concealing safety concerns of acetaminophen

Texas Attorney General Ken Paxton is suing the manufacturers of Tylenol, asserting the corporations withheld potential risks that the drug created to children's neurological development.

The lawsuit comes thirty days after Donald Trump publicized an unsubstantiated connection between consuming Tylenol - also known as acetaminophen - while pregnant and autism spectrum disorder in children.

Paxton is filing suit against Johnson & Johnson, which previously sold the drug, the exclusive pain medication approved for women during pregnancy, and Kenvue, which presently makes it.

In a statement, he claimed they "betrayed America by making money from suffering and pushing pills ignoring the potential hazards."

The company asserts there is insufficient reliable data connecting acetaminophen to autism spectrum disorder.

"These companies lied for decades, deliberately risking millions to increase profits," the attorney general, a Republican, declared.

Kenvue said in a statement that it was "seriously troubled by the spread of false claims on the security of acetaminophen and the potential impact that could have on the welfare of women and children in America."

On its website, the company also mentioned it had "consistently assessed the pertinent research and there is lacking reliable evidence that indicates a established connection between taking paracetamol and autism spectrum disorder."

Groups speaking for doctors and health professionals agree.

ACOG has said acetaminophen - the primary component in acetaminophen - is a restricted selection for expectant mothers to manage discomfort and fever, which can create serious health risks if left untreated.

"In more than two decades of investigation on the use of acetaminophen in gestation, no reliable research has successfully concluded that the use of paracetamol in any stage of gestation causes neurodevelopmental disorders in young ones," the group stated.

The lawsuit cites current declarations from the former administration in arguing the drug is potentially dangerous.

Recently, the former president generated worry from medical authorities when he instructed expectant mothers to "fight like hell" not to consume acetaminophen when unwell.

The US Food and Drug Administration then published an announcement that doctors should consider limiting the consumption of acetaminophen, while also mentioning that "a causal relationship" between the medication and autism in children has not been established.

Health Secretary RFK Jr, who oversees the FDA, had vowed in April to conduct "comprehensive study program" that would determine the cause of autism spectrum disorder in a matter of months.

But specialists cautioned that identifying a single cause of autism spectrum disorder - believed by scientists to be the consequence of a complicated interplay of genetic and environmental factors - would prove challenging.

Autism is a form of permanent neurological difference and condition that affects how people encounter and interact with the environment, and is recognized using medical professional evaluations.

In his court filing, Paxton - aligned with the former president who is campaigning for federal office - claims Kenvue and J&J "willfully ignored and sought to suppress the science" around paracetamol and autism spectrum disorder.

The case seeks to make the corporations "remove any marketing or advertising" that asserts Tylenol is safe for women during pregnancy.

The Texas lawsuit parallels the concerns of a group of mothers and fathers of children with autism and attention deficit hyperactivity disorder who sued the manufacturers of acetaminophen in two years ago.

Judicial authorities rejected the lawsuit, stating research from the family's specialists was lacking definitive proof.

Amy Ray
Amy Ray

A seasoned gambling analyst with over a decade of experience in reviewing online casinos and providing strategic advice for UK players.